Orchestra BioMed Holdings, Inc. Operating Lease, Payments
Orchestra BioMed Holdings, Inc. (OBIO) reported Operating Lease, Payments of $524.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. operating lease, payments for the quarter ending 2026-06-30 was $267.00K, a 3.09% increase year-over-year.
- Orchestra BioMed Holdings, Inc. operating lease, payments for the quarter ending 2026-03-31 was $257.00K, a 5.33% increase year-over-year.
- Orchestra BioMed Holdings, Inc. operating lease, payments for the quarter ending 2025-12-31 was $9.00K, a 95.69% decline year-over-year.
- Orchestra BioMed Holdings, Inc. operating lease, payments for the quarter ending 2025-09-30 was $232.00K, a 2.20% increase year-over-year.
- Orchestra BioMed Holdings, Inc. operating lease, payments for fiscal 2025 was $744.00K, a 16.40% decline from fiscal 2024.
- Orchestra BioMed Holdings, Inc. operating lease, payments for fiscal 2024 was $890.00K, a 0.89% decline from fiscal 2023.
- Orchestra BioMed Holdings, Inc. operating lease, payments for fiscal 2023 was $898.00K, a 27.92% increase from fiscal 2022.
- Orchestra BioMed Holdings, Inc. operating lease, payments for fiscal 2022 was $702.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $267.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $524.00K 10-Q · filed 2026-08-10 | $533.00K derived: sum of 3 quarters · filed 2026-08-10 | $765.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $257.00K 10-Q · filed 2026-05-12 | $266.00K derived: sum of 2 quarters · filed 2026-05-12 | $498.00K derived: sum of 3 quarters · filed 2026-05-12 | $757.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $241.00K derived: sum of 2 quarters · filed 2026-03-12 | $500.00K derived: sum of 3 quarters · filed 2026-08-10 | $744.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $232.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $491.00K derived: sum of 2 quarters · filed 2026-08-10 | $735.00K 10-Q · filed 2025-11-10 | $944.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $259.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $503.00K 10-Q · filed 2026-08-10 | $712.00K derived: sum of 3 quarters · filed 2026-08-10 | $939.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $244.00K 10-Q · filed 2026-05-12 | $453.00K derived: sum of 2 quarters · filed 2026-05-12 | $680.00K derived: sum of 3 quarters · filed 2026-05-12 | $906.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $436.00K derived: sum of 2 quarters · filed 2026-03-12 | $662.00K derived: sum of 3 quarters · filed 2026-03-12 | $890.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $227.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $453.00K derived: sum of 2 quarters · filed 2025-11-10 | $681.00K 10-Q · filed 2025-11-10 | $910.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $226.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $454.00K 10-Q · filed 2025-08-12 | $683.00K derived: sum of 3 quarters · filed 2025-08-12 | $942.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $228.00K 10-Q · filed 2025-05-12 | $457.00K derived: sum of 2 quarters · filed 2025-05-12 | $716.00K derived: sum of 3 quarters · filed 2025-05-12 | $921.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $488.00K derived: sum of 2 quarters · filed 2025-03-31 | $693.00K derived: sum of 3 quarters · filed 2025-03-31 | $898.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $259.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $464.00K derived: sum of 2 quarters · filed 2024-11-12 | $669.00K 10-Q · filed 2024-11-12 | $792.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $205.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $410.00K 10-Q · filed 2024-08-12 | $533.00K derived: sum of 3 quarters · filed 2024-08-12 | $758.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $205.00K 10-Q · filed 2024-05-13 | $328.00K derived: sum of 2 quarters · filed 2024-05-13 | $553.00K derived: sum of 3 quarters · filed 2024-05-13 | |
| 2022-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $348.00K derived: sum of 2 quarters · filed 2024-03-27 | $702.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $225.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $579.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $354.00K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |